Russian Journal of AllergyRussian Journal of AllergyРоссийский Аллергологический Журнал1810-88302686-682XPublishing House ABV Press70410.36691/RJA704ArticlesСтатьиResearch ArticleTOPICAL TREATMENT OF ATOPIC DERMATITIS IN CHILDREN: DIFFERENTIATED APPROACHНАРУЖНАЯ ТЕРАПИЯ АТОПИЧЕСКОГО ДЕРМАТИТА У ДЕТЕЙ -ДИФФЕРЕНЦИРОВАННЫЙ ПОДХОДSmirnovaG IСмирноваГалина Ивановнаsmimov@nczd.ruFirst Moscow State Medical University named after I. M. SetchenovПервый Московский государственный медицинский университет им. И.М. Сеченова1510201295NO5 (2012)№5 (2012)465410032020Copyright ©; 2012, Pharmarus Print MediaCopyright ©; 2012, Фармарус Принт Медиа2012Pharmarus Print MediaФармарус Принт Медиаhttps://rusalljournal.ru/raj/article/view/704

The article is devoted to mechanisms of atopic dermatitis, modern topical treatment and usefulness of topical emollients in children

Представлены данные о механизмах формирования атопического дерматита (АтД) и методах его дифференцированной наружной терапии у детей. описаны основные направления патогенетически обоснованного лечения АтД. Детально представлена наружная терапия атопических повреждений кожи у детей с использованием средств современной дерматологической косметики.

atopic dermatitischildrentreatmenttopical emollientsатопический дерматитдетилечениеуход за кожейэмолиентыСмирнова Г.И. Современная концепция лечения атопического дерматита. «ММА им. И.М. Сеченова». М., 2006, 132 с.DaVeiga S.P. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc. 2012, v. 33, p. 227-234.Scheinmann P, Pham Thi N., Karila C. et al. Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy. Arch. Pediatr. 2012, v. 19, p. 330-334.Van Beelen A.J., Teunissen M.B., Kapsenberg M.L. et al. Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 2007, v. 7, p. 374-381.Raap U., Weißmantel S., Gehring M. et al. IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr. Allergy Immunol. 2012, v. 23, p. 285-288.Savinko T, Matikainen S., Saarialho-Kere U. et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J. Invest. Dermatol. 2012, v. 132, p. 1392-1400.Kezic S., O’Regan G.M., Yau N. et al. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy. 2011, v. 66, p. 934-940.Kim B.E., Leung D.Y Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol. Res. 2012, v. 4, p. 120-126.Kezic S., O’Regan G.M., Lutter R. et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J. Allergy Clin. Immunol. 2012, v. 129, p. 1031-1039.Mizutani Y., Mitsutake S., Tsuji K. et al. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie. 2009, v. 91, p. 784-790.Cornelissen C., Marquardt Y., Czaja K. et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models J. Allergy Clin. Immunol. 2012, v. 129, p. 426-433.Burks A.W., Tang M., Sicherer S. et al. ICON: food allergy. J. Allergy Clin. Immunol. 2012, v. 129, p. 906-920.Bergstrom K.G. Truth or fiction: risk factors for childhood atopic dermatitis. J. Drugs Dermatol. 2012, v. 11, p. 126-128.Novak N. New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy. 2009, v. 64, p. 265-275.Daehnhardt-Pfeiffer S., Surber C., Wilhelm K.P et al. Noninvasive stratum corneum sampling and electron microscopical examination of skin barrier integrity: pilot study with a topical glycerin formulation for atopic dermatitis. Skin Pharmacol. Physiol. 2012, v. 25, p. 155-161.Смирнова Г.И. Эмольянты в наружной терапии атопического дерматита у детей. Рос. педиатр. журн. 2011, № 4, c. 37-42.Kircik L.H., Del Rosso J.Q. Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J. Clin. Aesthet. Dermatol. 2011, v. 4, p. 25-31.Koga C., Kabashima K., Shiraishi N. et al. Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 2008, v. 128, p. 2625-2630.Hon K.L., Wang S.S., Wong W.L. et al. Skin prick testing in atopic eczema: atopic to what and at what age? World J. Pediatr. 2012, v. 8, p. 164-168.Ring J., Alomar A., Bieber T et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part I. J. Eur. Acad. Dermatol. Venereol. 2012, v. 26, p. 1045-1060.Ring J., Alomar A., Bieber T. et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part II. J. Eur. Acad. Dermatol. Venereol. 2012, v. 26, p. 1176-1193.Yin Z.Q., Zhang W.M., Song G.X. et al. Meta-analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis. J. Dermatol. 2012, v. 39, p. 520-526.Shi V.Y., Tran K., Lio P.A. A comparison of physicochemical properties of a selection of modern moisturizers: hydrophilic index and pH. J. Drugs Dermatol. 2012, v. 11, p. 633-636.Verdier-Sévrain S., Bonté F. Skin hydration: a review on its molecular mechanisms. J. Cosmet. Dermatol. 2007, v. 6, p. 75-82.